IMC-M113V

N/A

Report date: 2022/07/19 16:08:20

Base Information

Drug NameIMC-M113V
Drug Alias NameImmTAVIMC-M113VIMC-M-113-V
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionHIV Gag polyprotein inhibitors
TargetsHIV Gag polyprotein
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunocore Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmunocore Holdings PLCBill And Melinda Gates Foundation
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A